Respiratory studies—particularly those for COPD—pose extraordinary logistical and clinical challenges for sponsors. INC Research/inVentiv Health, having extensive experience in conducting COPD trials, has developed unique ways to overcome these challenges. We combine novel recruitment and retention strategies with innovations in study design to reduce risks and ensure that COPD trials complete on time and produce high quality data.
In the last five years, we’ve conducted over 70 Phase I-IV respiratory studies—encompassing allergy, asthma, COPD, and cystic fibrosis— involving more than 34,175 subjects in over 3,087 investigative sites worldwide.
INC Research/inVentiv Health has extensive experience in managing the challenges in COPD trials throughout the various stages of study design, execution, oversight, and data analysis and interpretation.
The members of our highly skilled medical team have, on average, 15 years of in-patient and out-patient clinical experience in respiratory therapy areas involving several differentiated protocols and spanning 47 countries.
INC Research/inVentiv Health has conducted nearly 40 COPD studies, >26,586 subjects and >2,318 investigative sites in 33 countries since 2009